The assay runs on Roche's cobas® i 601 analyzer, part of the cobas® Mass Spec solution. By combining mass spectrometry's sensitivity and specificity with a standardized, easy-to-use workflow, the ...

Roche's acquisition of 89bio aims to strengthen its portfolio in cardiovascular, renal, and metabolic diseases, focusing on obesity-related comorbidities like MASH. The merger agreement includes a $14 ...

Lead With Us -- a promise for innovative partnerships, better insights, faster support, and improved healthcare outcomes. INDIANAPOLIS and CHICAGO, July 24, 2025 /PRNewswire/ -- Roche (SIX: RO, ROG; ...

Pharmaceutical and diagnostics giant Roche announced it will fund a $550 million diagnostic center in Indianapolis by 2030. The manufacturing hub will produce Roche's continuous glucose monitoring ...

HERLEV, Denmark , May 8, 2025 /PRNewswire/ -- Nordic Bioscience announces that its PRO-C3 test is launched by Roche Diagnostics on their cobas analysers. The Roche Elecsys® PRO-C3, used with the ADAPT ...

Diabetes and insulin management software company Glytec and pharmaceutical firm Roche are teaming up to allow the use of Glytec's software in connection with Roche's point-of-care smart-device ...

A blood test that measures lipoprotein(a) [Lp(a)] has received breakthrough device designation from the US Food and Drug Administration. The Tina-quant Lp(a) RxDx assay, developed by Roche in ...

you may also raise your virtual hand to address your questions verbally. [Operator Instructions] One last remark, if you would like to follow the presented slides on ...

My name is Henrik, and I'm the technical operator for today's call. Kindly know that the webinar is being recorded. [Operator Instructions]. One last remark. If you would like to follow the presented ...

NEW YORK – With the launch of its new Cobas Pure Integrated Solutions platform, Roche is aiming to address the needs of low- to mid-volume laboratories, namely those found in integrated health system ...

INDIANAPOLIS, Sept. 19, 2022 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the cobas ® pure integrated solutions, ...